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Foot-and-mouth disease virus shows remarkable thermal lability, a property that is a particular problem for
vaccine preparations. In this issue of Structure, Rinco´n and colleagues show that electrostatic repulsion
within the capsid is responsible for this lability, and they present rationally designed mutants with increased
thermostability.Foot-and-mouth disease is a highly con-
tagious livestock disease (Grubman and
Baxt, 2004). It is endemic in Asia, South
America, and Africa and sporadically
occurs in other regions, as exemplified
by the outbreaks in the UK in 2001 that
led to large economic losses. The causal
agent of the disease is a picornavirus,
foot-and-mouth disease virus (FMDV).
Vaccines made from inactivated virus
particles are available; however, the low
stability of the virus leads to its rapid
dissociation with a consequent loss of
ability to induce an effective immune
response.
Virus capsids comprise giant protein
assemblies with highly symmetrical
architectures. FMDV has an icosahedral
capsid, made up of 60 copies each of
the proteins VP1–VP3 and the peptide
VP4 assembled into 12 pentameric sub-
structures (Acharya et al., 1989). Heat
or acid will readily dissociate the capsid
into pentamers. In fact, the instability of
FMDV at low pH facilitates uncoating of
the viral RNA that is contained inside the
capsid once the virus reaches the acidic
environment in the endosomes of infected
cells, and it is thus critical for a successful
infectious cycle (Carrillo et al., 1985).
However, for the purpose of vaccine
production the instability of FMDV is a
problem. There has been some success
in engineering acid resistance (Ellard
et al., 1999; Twomey et al., 1995), but
much less in engineering thermal resis-
tance (Ashcroft et al., 2005; Fiedler et al.,
2012; Mateo et al., 2008; Porta et al.,
2013). Vaccines based on engineered
FMDV capsids that can withstand higher
temperatures would be very useful,
considering the hot climate in many
endemic regions where socioeconomic
factors preclude adequate cold chain
distribution.A mutant with increased thermal sta-
bility, A2065H, was identified in previous
studies by the Mateu lab (Mateo et al.,
2008). However, the precise mechanism
by which the mutation increased capsid
stability had not been determined.
Could it be that the introduced histidine
residue exerted its stabilizing effect by
partially neutralizing nearby carboxyl-
ates, thus reducing interpentamer elec-
trostatic repulsion? To test this hypothe-
sis, Rinco´n et al. (2014; in this issue of
Structure) made a number of acidic-to-
neutral substitutions (Glu to Gln and
Asp to Asn) close to the pentamer inter-
faces. The authors tested the infectivity
of the mutants and found that the
majority of the engineered viruses were
infectious as well as genetically stable,
meaning that the original mutation was
preserved after amplification in cells.
The infectious virus variants were then
tested for thermal stability against disso-
ciation into pentamers. In three of the
studied variants, the carboxylate was
located in a buried position and partici-
pated in several interactions with other
residues. As expected, these mutants
were destabilized compared to the
parent. Upon acidic-to-neutral mutation
of six solvent-exposed carboxylates,
two variants displayed no change in
stability while four mutants (D2068N,
E2086Q, D3134N, and D3195N) were
significantly stabilized compared to the
parent, as shown by their slower disso-
ciation rates at 42C. Because all of
these stable mutants were infectious, it
is clear that a thermally labile capsid is
not a prerequisite for FMDV infectivity
per se. Very strikingly, Rinco´n et al.
(2014) next go on to show that calcu-
lations based on the very simple
Tanford-Kirkwood theoretical model of
electrostatics (Tanford and Kirkwood,Structure 22, November 4, 20141957) are able to predict the destabiliz-
ing effects of the residues.
Based on their results, Rinco´n et al.
(2014) propose a model for FMDV ther-
mostability that can be visualized using
an energy diagram, as shown in Figure 1.
The instability of the capsid, originating at
least in part from intrinsic electrostatic
repulsion involving residues D2068,
E2086, D3134, and D3195, will lead to
ready dissociation into pentamers even
at moderate temperatures. Thus, the
energy barrier between the associated
and dissociated states is very low. By
acidic-to-neutral mutations, electrostatic
repulsions will be ameliorated. This will
decrease the free energy of the assem-
bled (capsid) state, but will not affect the
free energy of the transition state where
the unfavorable electrostatic interactions
have not yet been formed. The net effect
will be an increase in the energy barrier
between the two states, leading to a
reduced rate of irreversible dissociation
at a certain temperature; the capsid has
been kinetically stabilized.
The results of Rinco´n et al. (2014)
represent a significant advancement in
the field. They show that viral capsid
stability can be rationally engineered by
changes in electrostatic interactions and
that these mutant effects can be pre-
dicted using a very simple theoretical
model. Not only could this strategy prove
beneficial when designing vaccines
against various diseases, both traditional
vaccines based on inactivated virus and
vaccines in the form of recombinant
empty capsids, which are often even
less thermostable than the nucleic-acid
containing capsids (Curry et al., 1997;
Porta et al., 2013), but also thermostable
capsids could have applications in nano-
technology as molecular containers for
the delivery of drugs and other smallª2014 Elsevier Ltd All rights reserved 1549
Figure 1. Schematic Showing Kinetic Stabilization of FMDV by Mutation
The parent virus is in red and the virus with acidic-to-neutral mutation is in blue. The associated state, but
not the transition state (z) for irreversible dissociation into pentamers, is stabilized by themutations, result-
ing in increased kinetic stability of the capsid.
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Previewsmolecules. More generally, the results
provide interesting new insights into
how nature has designed giant macro-
molecular assemblies of incredibly beau-
tiful symmetries that are poised at just
the right amount of (in)stability for
optimal function. And, for those of us
attempting to build biomaterials from
self-assembling proteins de novo, it is a1550 Structure 22, November 4, 2014 ª2014humbling view of the design processes
involved.
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In an important addition to the chemokine field, Millard and colleagues, in this issue of Structure, report the
first structure of a CC chemokine in complex with a sulfated peptide derived from its receptor.Due to its significant impact on health
and disease, the chemokine system
has been a target of interest for both
academic research and pharmaceutical
applications for years. The chemokinesystem, encompassing about 50 chemo-
kine proteins that selectively bind to
one or several cognate chemokine re-
ceptors, forms a sophisticated network
that is critical in the mammalian immunesystem, mediating activation and chemo-
taxis of leukocytes and playing a role
in both homing and inflammation.
Dysfunction in the chemokine system
has been implicated in health issues
